Form 4: Evolent Health Director Kim Keck Acquires Shares in Open Market

Director Kim Keck of Evolent Health, Inc. purchased 10,540 shares of Class A Common Stock at a weighted average price of $9.44 on March 7, 2025.

Summary

• On March 7, 2025, Kim Keck, a director of Evolent Health, Inc., acquired 10,540 shares of Class A Common Stock.
• The shares were purchased at a weighted average price of $9.44, with individual prices ranging from $9.09 to $9.47.
• Following the transaction, Keck directly owns 39,522 shares of Evolent Health, Inc.
• This total includes restricted stock units granted under previous awards.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of stock purchase by a director. The purchase itself can be seen as slightly positive, but the document is primarily informational.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of insider trading activity, which is common for publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The stock purchase by a director could have a minor positive impact on shareholder sentiment.

Key Dates